Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

BLSM · ISSUER CIK 1839970

BlossomHill Therapeutics, Inc.

Between Aug 1, 2026 and Oct 29, 2026, 9 BlossomHill Therapeutics, Inc. insiders reported $25.2M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Gordon Carl L (Director), with $10.0M.

SEC insider filings
↗9 insiders filed

Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.

$25.2MInsider buying
$0.00Insider selling
+$25.2MNet open-market
Aug 12, 2026Latest filing
Form 4 trades at BlossomHill Therapeutics, Inc.
TickerInsiderTypeOwned
Aug 12, 202616:46Aug 10, 2026BLSMDirectorP · Buy$16.00+625,0002,714,279+30%+$10.0M0.0%-4.9%
Aug 12, 202616:46Aug 10, 2026BLSMDirectorC · Convert—+2,089,2792,089,279New—
Aug 12, 202616:43Aug 10, 2026BLSMDirector · +1 jointP · Buy$16.00+625,0002,714,279+30%+$10.0M0.0%-4.9%
Aug 12, 202616:43Aug 10, 2026BLSMDirector · +1 jointC · Convert—+2,089,2792,089,279New—
Aug 10, 202618:35Aug 10, 2026BLSMDirectorP · Buy$16.00+6,0006,000New+$96K0.0%-4.9%
Aug 10, 202618:32Aug 10, 2026BLSMDirector, 10% Owner · +5 jointP · Buy$16.00+312,5003,614,034+9%+$5.0M0.0%-4.9%
Aug 10, 202618:32Aug 10, 2026BLSMDirector, 10% Owner · +5 jointC · Convert—+3,301,5343,301,534New—
Aug 10, 202618:29Aug 10, 2026BLSMDirectorC · Convert—+578,524578,524New—
Aug 10, 202618:27Aug 10, 2026BLSMChief Financial OfficerP · Buy$16.00+700700New+$11K0.0%-4.9%
Aug 10, 202618:26Aug 10, 2026from Aug 7, 2026BLSMGeneral CounselP · Buy$15.89+4,700111,412+4%+$75K—-4.3%
Aug 10, 202618:26Aug 10, 2026BLSMGeneral CounselC · Convert—+22,68722,687New—
Aug 10, 202618:23Aug 10, 2026BLSMExecutive Chairman, Director, 10% OwnerC · Convert—+1,838,896124,779——
Aug 10, 202618:22Aug 10, 2026BLSMPresident and CEO, Director, 10% OwnerC · Convert—+1,838,896124,779——
BlossomHill Therapeutics, Inc. (BLSM) Insider Trading | Shameless Cloning